| Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845) |
|---|
| 05/16/2002 | WO2002038584A1 Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
| 05/16/2002 | WO2002038582A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | WO2002038581A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | DE10056676A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction |
| 05/16/2002 | DE10056675A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from estradienone by multi-stage process including selective Grignard reaction |
| 05/15/2002 | CA2348206A1 Isomerisation of 6beta-fluorosteroids into the corresponding 6alpha-fluoro derivatives |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/24/2002 | CN1345728A Solasodine hydrochlorate and productive method and application in medicine |
| 04/23/2002 | US6376687 Steroid sulfatase inhibitors and methods for making and using the same |
| 04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030366A1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/18/2002 | DE10048634A1 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring 19-Nor-17alpha-pregna-1,3,5 (10) triene-17beta-ols with a 21, 16alpha-lactone |
| 04/18/2002 | CA2425356A1 Hedgehog antagonists, methods and uses related thereto |
| 04/11/2002 | US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 04/09/2002 | US6369218 Isomerisation of 6β-fluorosteroids into the corresponding 6α-fluoro derivatives |
| 04/04/2002 | WO2002026763A1 19-NOR-17α-PREGNA-1,3,5 (10)-TRIEN-17β-OLS OF A 21,16α-LACTONE RING |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | CA2422056A1 17.alpha. fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 04/03/2002 | CN1342657A Compound extracted from manatee for suppressing generation of new blood vessel in tumor |
| 04/03/2002 | CN1342656A Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/21/2002 | WO2002022647A1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 03/21/2002 | WO2002022646A2 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) |
| 03/21/2002 | WO2002022121A1 Fungicidal saponin, cay-1, and isolation thereof from capsicum species fruit |
| 03/21/2002 | US20020035260 4-aza-steroids |
| 03/21/2002 | CA2419960A1 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) |
| 03/20/2002 | CN1081036C Anticarcinogen |
| 03/14/2002 | US20020032179 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder |
| 03/13/2002 | CN1340056A Steroides sulfatase inhibitors and methods for making and using same |
| 03/07/2002 | WO2002017895A2 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/07/2002 | CA2419256A1 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
| 03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
| 03/05/2002 | US6352697 Immunostimulating complex matrices; quil a fractions |
| 02/28/2002 | WO2001053321A3 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/27/2002 | EP0970105B1 Process for preparing carboxamido-4-azasteroids |
| 02/21/2002 | WO2001049703A3 Substituted sapogenins and their use |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/14/2002 | US20020019522 Steroids |
| 02/14/2002 | US20020019378 Compounds |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 02/07/2002 | WO2002009760A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | US20020016481 Oxireno-, azetidino-, and methano- picene derivatives |
| 02/07/2002 | US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/06/2002 | EP1177204A2 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 01/30/2002 | EP1175434A2 Eplerenone crystalline form |
| 01/30/2002 | EP1175433A1 Androgen glycosides and androgenic activity thereof |
| 01/24/2002 | WO2001034132A3 Use of an aldosterone antagonist for treating restenosis |
| 01/23/2002 | EP1173430A1 Enantiomers of mercapto lactones and processes for their synthesis |
| 01/23/2002 | CN1078072C Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 01/17/2002 | WO2002004410A1 Process for producing sulfamate compound |
| 01/16/2002 | EP0923599B1 Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones |
| 01/15/2002 | US6339079 Steroid sulfamates, method for the production and use thereof |
| 01/09/2002 | EP1170299A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | WO2000071563A3 Taccalonolide microtubule stabilizing agents |
| 01/02/2002 | EP1167381A2 Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein |
| 01/02/2002 | EP1167380A2 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1165596A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 01/01/2002 | US6335441 5β-cyano-substituted steroid compounds |
| 12/27/2001 | WO2001098322A1 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |
| 12/26/2001 | CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/12/2001 | EP0806413B1 2-substituted vitamin d3 derivatives |
| 12/12/2001 | EP0785802B1 Saponin preparations and use thereof in iscoms |
| 12/05/2001 | EP1158988A2 Corticosteroid formulation |
| 11/29/2001 | WO2001042272A3 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 11/29/2001 | US20010047093 Activation of a diels-alder reaction of a sterol 5,7 diene |
| 11/22/2001 | WO2001041535A3 Eplerenone crystalline form |
| 11/21/2001 | CN1322729A Acylated derivative of dioscin and its producing process and use |
| 11/15/2001 | WO2001085174A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases |
| 11/15/2001 | CA2408647A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases |
| 11/14/2001 | EP0686613B1 Ozonide reducing agent |
| 11/08/2001 | WO2001083512A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 11/08/2001 | CA2418748A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 11/06/2001 | US6313161 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylase inhibitors and methods of their use in the treatment of estrogen mediated disorders |
| 10/30/2001 | US6310225 Useful as intermediates for producing vitamin d derivates |
| 10/30/2001 | US6310091 Fungicidal saponin, CAY-1, and isolation thereof from Capsium species fruit |
| 10/24/2001 | EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein |
| 10/24/2001 | EP1147124A2 Steroid sulfatase inhibitors and methods for making and using the same |
| 10/23/2001 | US6306862 Treatment of liver disorders |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 09/27/2001 | WO2001070760A1 Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst |
| 09/26/2001 | CN1071574C Use of 1 alpha, 24-dihydroxy vitamin D2 |